Cargando…
Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery?
BACKGROUND: Sentinel lymph node biopsy (SLNB) is standard care to evaluate axillary involvement in early breast cancer. It has fewer complications than complete lymph node dissection; however, using blue dye in SLNB is controversial. We have evaluated the detection rate and local complications assoc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274565/ https://www.ncbi.nlm.nih.gov/pubmed/25538772 |
_version_ | 1782350001116020736 |
---|---|
author | Fattahi, Asieh Sadat Tavassoli, Alireza Rohbakhshfar, Omid Sadeghi, Ramin Abdollahi, Abbas Forghani, Mohammad Naser |
author_facet | Fattahi, Asieh Sadat Tavassoli, Alireza Rohbakhshfar, Omid Sadeghi, Ramin Abdollahi, Abbas Forghani, Mohammad Naser |
author_sort | Fattahi, Asieh Sadat |
collection | PubMed |
description | BACKGROUND: Sentinel lymph node biopsy (SLNB) is standard care to evaluate axillary involvement in early breast cancer. It has fewer complications than complete lymph node dissection; however, using blue dye in SLNB is controversial. We have evaluated the detection rate and local complications associated with methylene blue dye (MBD) used in SLNB in early breast cancer patients and compared these results to patent blue dye (PBD). MATERIALS AND METHODS: In a cohort prospective study, 312 patients with early breast cancer without axillary lymph node involvement were divided into two groups according to dye type. All of the patients received radiotracer and one type of blue dye. We filled out a checklist for the patients that contained demographic data, size of tumor, stage, detection of sentinel lymph node, and complications and then analyzed the data. RESULTS: Demographic and histopathologic characteristics were not significantly different in both groups. Mean (standard deviation [SD]) tumor size in all patients was 2.4 (0.8) cm. Detection rate in the MBD group was 77.5% with dye alone and 94.2% with dye and radioisotope; and in the PBD group it was 80.1% and 92.9% respectively (P > 0.05). We had blue discoloration of the skin in 23.7% in the PBD and 14.1% in the MBD group (P < 0.05) local inflammation was detected in one patient in the PBD and five in the MBD group (P < 0.05). Skin necrosis and systemic complications were not observed. CONCLUSION: Methylene blue has an acceptable detection rate, which may be a good alternative in SLNB. Complication such as blue discoloration of the skin was also lower with MBD. |
format | Online Article Text |
id | pubmed-4274565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42745652014-12-23 Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? Fattahi, Asieh Sadat Tavassoli, Alireza Rohbakhshfar, Omid Sadeghi, Ramin Abdollahi, Abbas Forghani, Mohammad Naser J Res Med Sci Original Article BACKGROUND: Sentinel lymph node biopsy (SLNB) is standard care to evaluate axillary involvement in early breast cancer. It has fewer complications than complete lymph node dissection; however, using blue dye in SLNB is controversial. We have evaluated the detection rate and local complications associated with methylene blue dye (MBD) used in SLNB in early breast cancer patients and compared these results to patent blue dye (PBD). MATERIALS AND METHODS: In a cohort prospective study, 312 patients with early breast cancer without axillary lymph node involvement were divided into two groups according to dye type. All of the patients received radiotracer and one type of blue dye. We filled out a checklist for the patients that contained demographic data, size of tumor, stage, detection of sentinel lymph node, and complications and then analyzed the data. RESULTS: Demographic and histopathologic characteristics were not significantly different in both groups. Mean (standard deviation [SD]) tumor size in all patients was 2.4 (0.8) cm. Detection rate in the MBD group was 77.5% with dye alone and 94.2% with dye and radioisotope; and in the PBD group it was 80.1% and 92.9% respectively (P > 0.05). We had blue discoloration of the skin in 23.7% in the PBD and 14.1% in the MBD group (P < 0.05) local inflammation was detected in one patient in the PBD and five in the MBD group (P < 0.05). Skin necrosis and systemic complications were not observed. CONCLUSION: Methylene blue has an acceptable detection rate, which may be a good alternative in SLNB. Complication such as blue discoloration of the skin was also lower with MBD. Medknow Publications & Media Pvt Ltd 2014-10 /pmc/articles/PMC4274565/ /pubmed/25538772 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Fattahi, Asieh Sadat Tavassoli, Alireza Rohbakhshfar, Omid Sadeghi, Ramin Abdollahi, Abbas Forghani, Mohammad Naser Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? |
title | Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? |
title_full | Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? |
title_fullStr | Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? |
title_full_unstemmed | Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? |
title_short | Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? |
title_sort | can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274565/ https://www.ncbi.nlm.nih.gov/pubmed/25538772 |
work_keys_str_mv | AT fattahiasiehsadat canmethylenebluedyebeusedasanalternativetopatentbluedyetofindthesentinellymphnodeinbreastcancersurgery AT tavassolialireza canmethylenebluedyebeusedasanalternativetopatentbluedyetofindthesentinellymphnodeinbreastcancersurgery AT rohbakhshfaromid canmethylenebluedyebeusedasanalternativetopatentbluedyetofindthesentinellymphnodeinbreastcancersurgery AT sadeghiramin canmethylenebluedyebeusedasanalternativetopatentbluedyetofindthesentinellymphnodeinbreastcancersurgery AT abdollahiabbas canmethylenebluedyebeusedasanalternativetopatentbluedyetofindthesentinellymphnodeinbreastcancersurgery AT forghanimohammadnaser canmethylenebluedyebeusedasanalternativetopatentbluedyetofindthesentinellymphnodeinbreastcancersurgery |